PD patients treated with L-dopa showed a borderline significance ( p Observed = 0.05) for the abundance of predicted pathways when compared to the control group.
← all excerpts
Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota.
2
—
—
The sentences
Previous studies found a borderline significant influence of L-dopa on the total gut microbiome or discussed the treatment with L-dopa as a possible influencing factor. 14 , 22 , 32 Furthermore, a recent study showed the important role of microbial metabolism in drug availability and degradation in the gut. 20 However, as far as we know, no study specifically addressed changes in microbial community composition in PD related to L-dopa medication in detail.